Syqe® Medical’s groundbreaking SyqeAir Inhaler is revolutionizing medical cannabis treatment. Thus argues a recent article by The Jerusalem Post, which discusses the significant impact of Syqe®’s technology on treating chronic pain and PTSD patients. SyqeAir allows fast pain relief without psychoactive side effects. Discover how Syqe® is setting a new standard in medical cannabis care with prestigious recognition from one of Israel’s leading publications. Read the article>>
Bedrocan highlights SyqeAir’s TGA Approval in Australia
An article by Bedrocan about Syqe® receiving the Therapeutic Goods Administration (TGA) approval for the SyqeAir inhaler in Australia. This significant regulatory milestone is a step forward in the global expansion of our treatment.